Dyne Therapeutics
DYN
NASDAQ
IPO2020
about DYN
Dyne Therapeutics is a biotechnology company focused on advancing innovative gene-editing and gene-therapy treatments targeting rare diseases with significant unmet needs.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $23.40 | $24.95 | $23.00 | $2.44B | 12.67M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.97 | n/a | n/a | 0% | 0% | 0% |